Literature DB >> 8530062

The mouse mutation progressive motor neuronopathy (pmn) maps to chromosome 13.

A L Brunialti1, C Poirier, H Schmalbruch, J L Guénet.   

Abstract

Analysis of polymorphic markers segregating in both intra- and interspecific crosses has allowed us to map the autosomal recessive mutation progressive motor neuronopathy (pmn) to mouse Chr 13. Although this mutation, based on its histological description, was reported as a model for infantile spinal muscular atrophy of the Werdnig-Hoffmann type, its localization to a region that is not homologous with human 5q makes it unlikely to be a homologue to SMA. The presence of the Extra-toe (Xt) locus in proximity to pmn will help in the detection of affected progenies before the onset of the degenerative process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530062     DOI: 10.1006/geno.1995.1223

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21.

Authors:  K Grohmann; T F Wienker; K Saar; S Rudnik-Schöneborn; G Stoltenburg-Didinger; R Rossi; G Novelli; G Nürnberg; A Pfeufer; B Wirth; A Reis; K Zerres; C Hübner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Physical mapping of the beige critical region on mouse chromosome 13.

Authors:  S F Kingsmore; M D Barbosa; Q A Nguyen; J A Ashley; S M Blaydes; V T Tchernev; J C Detter; M Lovett
Journal:  Mamm Genome       Date:  1996-10       Impact factor: 2.957

3.  Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy.

Authors:  T Bordet; H Schmalbruch; B Pettmann; A Hagege; L Castelnau-Ptakhine; A Kahn; G Haase
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease.

Authors:  Y Sagot; N Toni; D Perrelet; S Lurot; B King; H Rixner; L Mattenberger; P C Waldmeier; A C Kato
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.